MAPT and Alzheimer disease: This study attempts to examine the neuroprotective effect of ferulic acid on BPA-induced AD-like pathology by evaluating spatial working and recognition behavior as well as brain oxidative stress, proinflammatory cytokines, and the neuropathological hallmark of AD, including beta-amyloid (1–42) and total and phosphorylated Tau protein deposition levels.